|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from financial institutions | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Fed funds sold | ||||||||||||||||||||
| Interest-bearing demand deposits | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities available-for-sale- at fair value | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost- approximate fair value of $210 and $259 at March 31, 2024 and June 30, 2023, respectively | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost-approximate fair value of $132 and $167 at June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of allowance of $2,126 and $1,634 at September 30, 2023 and June 30, 2023, respectively1 | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $2,257 and $2,170 at June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Real estate acquired through foreclosure | ||||||||||||||||||||
| Office premises and equipment - at depreciated cost | ||||||||||||||||||||
| Federal Home Loan Bank stock - at cost | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Prepaid income taxes | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Savings | ||||||||||||||||||||
| Certificates of deposit | ||||||||||||||||||||
| Demand deposit accounts | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Advances by borrowers for taxes and insurance | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Accrued income taxes | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Common stock, 20,000,000 shares authorized, $.01 par value; 8,596,064 shares issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings - restricted | ||||||||||||||||||||
| Treasury shares at cost, 509,349 common shares at June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
